REQUEST A DEMO
Total
USD $0.00
Search more companies

Daewoong Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Daewoong Pharmaceutical Co.,Ltd. Profile Updated: September 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Daewoong Pharmaceutical (Thailand) Co., Ltd is a healthcare enterprise that focuses on developing products and stem cell therapy for autoimmune diseases and chronic conditions. The company offers solutions through biotechnology and continuous research and development, and also focuses on developing and producing new drugs, biologics, and modified drugs.

Headquarters
223-23 Sangdaewon-Dong, Jungwon-Gu, Seongnam-Si
Seongnam; Gyeonggi; Postal Code: 462-807

Contact Details: Purchase the Daewoong Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.daewoong.co.kr

Basic Information
Total Employees:
Purchase the Daewoong Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Daewoong Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Daewoong Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Daewoong Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
October 01, 2002
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
3.49%
Purchase this report to view the information.
0.52%
Purchase this report to view the information.
0.3%
Purchase this report to view the information.
0.06%
Purchase this report to view the information.
0.03%
Subsidiaries
Daewoong Chemical Co Ltd
Daewoong Co.,Ltd. (Seongnam)
Daewoong Endowment Foundation
Company Performance
Financial values in the chart are available after Daewoong Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
3.53%
Total operating revenue
3.21%
Operating profit (EBIT)
-39.2%
EBITDA
7.44%
Net Profit (Loss) for the Period
-84.49%
Total assets
14.05%
Total equity
9.87%
Operating Profit Margin (ROS)
-3.58%
Net Profit Margin
-5.37%
Return on Equity (ROE)
-4.43%
Debt to Equity Ratio
10.86%
Quick Ratio
-0.09%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?